BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8314159)

  • 21. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
    Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
    N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
    Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
    N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
    Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
    Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
    Estrov Z; Grunberger T; Dubé ID; Wang YP; Freedman MH
    N Engl J Med; 1986 Aug; 315(9):538-42. PubMed ID: 3488505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis.
    Knulst AC; Adriaansen HJ; Hählen K; Stigter JC; van den Beemd MW; Hagemeijer A; van Dongen JJ; Hooijkaas H
    Leukemia; 1993 Apr; 7(4):532-6. PubMed ID: 8464231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias".
    Invernizzi R; Rosanda C; Basso G; Conter V; di Cataldo A; Fenu S; Forni M; Frappampina V; Granchi D; Locatelli F
    Haematologica; 1992; 77(1):30-4. PubMed ID: 1383101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of 14 patients with philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remission.
    Mizuta S; Kohno A; Morishita Y; Atsuta Y; Sao H; Miyamura K; Sakamaki H; Ueda R; Morishima Y
    Int J Hematol; 2007 Feb; 85(2):140-5. PubMed ID: 17321992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
    Smedmyr B; Bengtsson M; Jakobsson A; Simonsson B; Oberg G; Tötterman TH
    Eur J Haematol; 1991 Mar; 46(3):146-51. PubMed ID: 1826271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.
    Janossy G; Campana D; Burnett A; Coustan-Smith E; Timms A; Bekassy AN; Hann I; Alcorn MJ; Totterman T; Simonsson B
    Leukemia; 1988 Aug; 2(8):485-95. PubMed ID: 3045431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High proportions of CD4⁺ T cells among residual bone marrow T cells in childhood acute lymphoblastic leukemia are associated with favorable early responses.
    Lustfeld I; Altvater B; Ahlmann M; Ligges S; Brinkrolf P; Rosemann A; Moericke A; Rossig C
    Acta Haematol; 2014; 131(1):28-36. PubMed ID: 24021585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.
    Bregni M; Siena S; Neri A; Bassan R; Barbui T; Delia D; Bonadonna G; Dalla Favera R; Gianni AM
    J Clin Oncol; 1989 Mar; 7(3):338-43. PubMed ID: 2918330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunologic detection of minimal residual disease in acute leukemia.
    Campana D; Coustan-Smith E; Janossy G
    Blood; 1990 Jul; 76(1):163-71. PubMed ID: 1973061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of post-therapy residual testicular lymphoblasts in childhood acute lymphoblastic leukemia (ALL).
    Suc E; Robert A; Rubie H; Regnier C; Guitard J; Caveriviere P; al Saati T; Kuhlein E; Chittal S; Delsol G
    Pediatr Hematol Oncol; 1989; 6(2):121-35. PubMed ID: 2702066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission.
    Self SE; Morgan S; Grush O; La Via MF
    Hematol Oncol; 1990; 8(2):91-5. PubMed ID: 2140561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.